- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- homo-dimer
- Ligands
- 1 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x PHE: PHENYLALANINE(Non-covalent)
PHE.4: 10 residues within 4Å:- Chain A: R.90, H.223, F.227, R.322, Y.372, I.374, I.430, G.464, W.465
- Ligands: FAD.5
8 PLIP interactions:6 interactions with chain A, 2 Ligand-Ligand interactions- Hydrophobic interactions: A:I.374, A:I.430
- Hydrogen bonds: A:Y.372, A:G.464, F.4, F.4
- Water bridges: A:M.89
- Salt bridges: A:R.90
PHE.7: 10 residues within 4Å:- Chain B: R.90, H.223, F.227, R.322, Y.372, I.374, I.430, G.464, W.465
- Ligands: FAD.8
9 PLIP interactions:7 interactions with chain B, 2 Ligand-Ligand interactions- Hydrophobic interactions: B:I.374, B:I.430
- Hydrogen bonds: B:Y.372, B:G.464, F.7, F.7
- Water bridges: B:M.89, B:R.90
- Salt bridges: B:R.90
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
FAD.5: 37 residues within 4Å:- Chain A: V.39, G.40, A.41, G.42, M.43, A.44, L.62, E.63, A.64, G.69, G.70, R.71, V.72, G.87, P.88, M.89, R.90, L.91, A.259, Q.260, V.261, C.293, T.294, T.295, A.298, Y.372, W.420, Y.425, G.429, I.430, G.456, E.457, G.464, W.465, I.466, T.469
- Ligands: PHE.4
40 PLIP interactions:40 interactions with chain A- Hydrophobic interactions: A:W.420, A:I.430, A:I.430
- Hydrogen bonds: A:A.41, A:M.43, A:A.44, A:A.64, A:S.65, A:G.69, A:R.71, A:V.72, A:M.89, A:R.90, A:R.90, A:V.261, A:V.261, A:E.457, A:E.457, A:E.457, A:W.465, A:I.466
- Water bridges: A:G.42, A:G.45, A:E.63, A:S.65, A:G.70, A:R.71, A:R.71, A:Q.260, A:Q.260, A:Q.260, A:Q.260, A:Q.260, A:T.295, A:Y.372, A:D.467, A:T.469
- Salt bridges: A:R.71, A:R.71
- pi-Stacking: A:W.465
FAD.8: 38 residues within 4Å:- Chain B: V.39, G.40, A.41, G.42, M.43, A.44, L.62, E.63, A.64, G.69, G.70, R.71, V.72, G.87, P.88, M.89, R.90, L.91, A.259, Q.260, V.261, C.293, T.294, T.295, A.298, I.302, Y.372, W.420, Y.425, G.429, I.430, G.456, E.457, G.464, W.465, I.466, T.469
- Ligands: PHE.7
38 PLIP interactions:38 interactions with chain B- Hydrophobic interactions: B:W.420, B:I.430, B:I.430
- Hydrogen bonds: B:A.41, B:A.44, B:A.64, B:G.69, B:R.71, B:M.89, B:R.90, B:R.90, B:V.261, B:V.261, B:E.457, B:E.457, B:W.465, B:I.466
- Water bridges: B:G.42, B:M.43, B:G.45, B:E.63, B:S.65, B:G.70, B:R.71, B:R.71, B:V.72, B:Q.260, B:Q.260, B:Q.260, B:Q.260, B:Q.260, B:T.295, B:T.295, B:Y.372, B:D.467, B:T.469
- Salt bridges: B:R.71, B:R.71
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Moustafa, I.M. et al., Crystal Structure of LAAO from Calloselasma rhodostoma with an L-Phenylalanine Substrate: Insights into Structure and Mechanism. J.Mol.Biol. (2006)
- Release Date
- 2006-10-31
- Peptides
- L-amino-acid oxidase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- homo-dimer
- Ligands
- 1 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x PHE: PHENYLALANINE(Non-covalent)
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Moustafa, I.M. et al., Crystal Structure of LAAO from Calloselasma rhodostoma with an L-Phenylalanine Substrate: Insights into Structure and Mechanism. J.Mol.Biol. (2006)
- Release Date
- 2006-10-31
- Peptides
- L-amino-acid oxidase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
D